Sunday 24 November 2024

Pharma & Biotech Start-up & Scale-up News

Featured

NewAmsterdam Pharma
A Dutch clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Pharmaceutical
The week in pharma: action, reaction and insight – week to November 1
3 November 2024
Pharmaceutical
FDA panel vote leaves Lexicon’s Zynquista hopes hanging by a thread
1 November 2024

Latest Ones To Watch News

Biotechnology
Versant Ventures unveils obesity focused Pep2Tango Therapeutics
22 November 2024
Biotechnology
argenX spinoff secures series A extension to fight blood cancer
22 November 2024
Biotechnology
Enveda closes $130 million Series C funding
22 November 2024
More ones to watch news >
Reset all filters
Refine Search
Enanta Pharmaceuticals
Basilea
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma
SFA Therapeutics
Reunion Neuroscience
Atopia Therapeutics
Prologue Medicines
Lykos Therapeutics
Attovia Therapeutics
Ajax Therapeutics
Cartesian Therapeutics
AltruBio
Progentos Therapeutics


Today's issue

Otsuka gains global licensing rights from Ionis to ulefnersen
Pharmaceutical
Otsuka gains global licensing rights from Ionis to ulefnersen
23 November 2024
Biotechnology
Anti-CD20 MAb Rituxan approved for ITP in Japan
23 November 2024
Biotechnology
J&J powers on with Tremfya with UC SC filing
22 November 2024
Biotechnology
Takeda launches Fruzaqla in Japan
22 November 2024
Biotechnology
CStone out-licenses sugemalimab rights in MENA region
22 November 2024
Biotechnology
China's regulator to review Akeso's checkpoint blocker
22 November 2024
Biotechnology
Paragon Therapeutics appoints first chief executive
22 November 2024

Company Spotlight

A Dutch clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.




Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze